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Abstract
Objectives: To evaluate skin barrier and hydration effects of a new rebalancing mois-
ture treatment (TRMT) and to assess efficacy and tolerability in subjects with pho-
todamaged skin.
Methods: In an epidermal skin model, tissues (n = 5/group) were topically treated 
with 25 µL of TRMT, 25 µL of a market-leading moisturizer (MLM), or untreated for 
60 minutes. Hydration was measured at 0, 15, and 30 minutes. Tissues were har-
vested for gene expression analysis of markers associated with skin barrier and 
hydration: Claudin (CLD), Aquaporin (AQP), Hyaluronic Acid Syntheses (HAS), and 
Hyaluronidase (HYAL). A clinical study evaluated twice-daily application of TRMT, as-
sessing changes in fine lines/wrinkles, brightness, texture, erythema, and tolerability 
from baseline through week 8. Hydration was measured using electrical impedance.
Results: TRMT and MLM demonstrated significant increases in hydration vs un-
treated tissue at each timepoint (P < .005), with greater hydration effects observed 
for TRMT vs MLM. TRMT-treated tissues demonstrated greater expression of CLD, 
AQP, and HA, and reduced expression of HYAL vs untreated and MLM-treated tis-
sues. Twice-daily application of TRMT demonstrated significant improvements at 
2 weeks in fine lines/wrinkles (P < .001), brightness (P < .0001), texture (P < .0004), 
and hydration (P < .004). At 8 weeks, statistically significant improvements were 
achieved in all categories.
Conclusion: In an epidermal skin model, TRMT demonstrated significant increases in 
hydration, greater hydration effects, and expression of key markers associated with 
skin barrier and hydration vs a MLM. Twice-daily application of TRMT was well toler-
ated and resulted in early, significant improvements in hydration and visible improve-
ments in skin brightness, texture, fine lines/wrinkles, and erythema at 8 weeks.
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1  | INTRODUC TION
Youthful skin is characterized by its turgor, resilience, and pliabil-
ity, in large part owing to its high water content. Skin aging is a 
complex biological process that includes both intrinsic and ex-
trinsic factors. Natural skin aging is associated with a significant 
reduction in the capacity of skin to retain water, as well as de-
creased sebum production (particularly in women).1-4 In addition 
to intrinsic changes, extrinsic factors, including exposure to ultra-
violet (UV) radiation, smog, and cigarette smoke, also cause loss 
of skin hydration and impairments to barrier function.4,5 Together, 
these changes lead to dry skin and contribute to other aging-re-
lated manifestations, including fine lines and wrinkles, and dull and 
uneven skin tone and texture.
Skin is the first layer of defense against external insults to the 
body and is instrumental in protecting the body from harmful sub-
stances such as bacteria.1 Healthy, hydrated skin constantly renews 
itself to maintain the barrier's protective function.6 However, exces-
sive environmental exposure can compromise and overwhelm the in-
nate ability of the skin barrier to maintain and repair itself. Compared 
with adequately hydrated skin, dry or compromised skin, owing to 
aging or excessive environmental exposure, is characterized by a 
thicker stratum corneum and a weaker barrier.7,8 This manifests as 
xerosis and an increased vulnerability to infection, irritation, and al-
lergens, as well as other consequences associated with environmen-
tal insults, including malignancies and skin diseases.9,10 Skin requires 
adequate hydration levels to maintain epidermal barrier integrity and 
normal functional activities.6
Optimal water content is essential in maintaining a healthy bar-
rier as well as other health-related and cosmetic benefits to skin.11 
Three critical elements in supporting skin hydration include the 
maintenance of natural moisturizing factors (NMF), the skin's natural 
lipid bilayer, and hyaluronic acid (HA). These elements work together 
to facilitate and maintain moisturization of the epidermis and under-
lying skin structures to ensure a healthy barrier.
Natural moisturizing factors are comprised of a group of highly 
efficient humectants that attract and bind water from the atmo-
sphere and are essential to water retention in the stratum cor-
neum. Filaggrin, a large protein localized in the corneocyte layer in 
the stratum corneum, is converted to NMF in the more superficial 
layers of the stratum corneum.12 Proteolysis of filaggrin is depen-
dent on water activity within the corneocytes as well as exter-
nal relative humidity and can only occur within a narrow range 
of water activity within corneocytes.12 Of note, exposure to UV 
radiation has been shown to impair the natural degradation of fil-
aggrin into NMF.12
Components of NMF include amino acids and derivatives 
of amino acids, such as pyrrolidone carboxylic acid (PCA), lac-
tic acid, and urea. Lactic acid stimulates synthesis of ceramides 
and improves and prevents symptoms associated with xerosis; 
urea stimulates expression of enzymes involved in the synthesis 
of ceramides and aquaporins (AQPs). Often referred to as “water 
pores” or “water channels”, AQPs are transmembrane proteins 
that transport and distribute water (as well as glycerol and urea) 
throughout the epidermis.13,14 Sufficient levels of NMF maintain 
adequate hydration of the stratum corneum, skin plasticity, and 
optimize barrier function. Suboptimal levels of NMF can manifest 
clinically as dry skin with scaling, flaking, and cracking, and have 
been associated with conditions such as atopic dermatitis and 
psoriasis.7,8,12
Primary intercellular barrier lipids, including cholesterol, essen-
tial fatty acids (EFAs), and ceramides, work together to form a bar-
rier to prevent transepidermal water loss (TEWL). Barrier lipids help 
maintain skin's natural collagen, elastin, and proteins by minimizing 
TEWL, increasing hydration, and reinforcing the protective barrier. 
TEWL impairs the normal desquamation process, leading to dry flaky 
skin. All three barrier lipids are needed for proper maturation and 
natural skin desquamation in the stratum corneum.14 Notably, atopic 
dermatitis is characterized by a reduction in all three key barrier 
lipids.15 Corneocytes, where filaggrin originates, are embedded in 
the barrier lipids of the stratum corneum and have a primary role 
in supporting barrier function.16 Essential fatty acids are primarily 
composed of polyunsaturated fatty acids such as linoleic acid, which 
is the most abundant type of polyunsaturated fatty acid.
A third critical component involved in skin moisturization is hy-
aluronan or hyaluronic acid (HA). HA is a glycosaminoglycan (GAG) 
and predominant element of the extracellular matrix; the synthesis 
of epidermal HA is greatly influenced by the dermis. Hydration of the 
skin depends on HA's unique capacity to bind and retain water mol-
ecules in the dermis and epidermis. In addition to its rapid turnover 
rate in the skin (~24 hours), both intrinsic and extrinsic factors con-
tribute to a marked reduction of epidermal HA, making it one of the 
most dramatic changes observed in senescent skin.17 HA synthase 
(HAS) is an enzyme that facilitates HA synthesis; hyaluronidase is 
an enzyme that degrades HA. Skin moisturization is optimized by 
agents that maximize HAS and minimize HYAL.
A compromised skin barrier requires supplemental support that 
promotes synthesis of HA and inhibits its breakdown, as well as main-
tains sufficient levels of NMF and lipids to keep skin moisturized and 
hydrated. Moisturizers are an essential component of a skin-care 
regimen.18 Ideally, they mimic the skin's own natural moisturizing 
systems19 and help to rebalance skin by supporting barrier function 
and enhancing hydration. Using advanced chemistry, a unique mois-
turizing treatment cream (TRMT) has been developed to address the 
three critical elements to natural skin moisturization. The ingredi-
ents in TRMT were specifically selected to bolster adequate stratum 
corneum hydration by supporting NMF, enhance barrier function by 
maximizing lipid content of the skin, and replenish HA by supporting 
its synthesis and reducing its degradation (Table 1).
As part of a research program evaluating the efficacy of TRMT, 
we first investigated the effect of TRMT on hydration and analyzed, 
via gene expression, key markers associated with skin barrier func-
tion and hydration utilizing a reconstructed human epidermal skin 
model. In a second study, we examined the clinical efficacy and tol-
erability of TRMT over 8 weeks in healthy subjects with moderate to 
severe photodamaged skin.
--WILEY - t------------------------
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2  | E VALUATING SKIN HYDR ATION 
AND BARRIER EFFEC TS UTILIZING AN 
EPIDERMAL SKIN MODEL
2.1 | Objective
To evaluate TRMT and a market-leading moisturizer, via gene ex-
pression analysis, for effects on hydration and key epidermal barrier 
markers in a human epidermal skin model.
2.2 | Materials and methods
This study utilized highly differentiated, human epidermal skin tissues 
(EpiDermFT™; MatTek Corp.) comprised of normal, human-derived 
epidermal keratinocytes. This model contains organized and prolif-
erative basal cells, spinous and granular layers, as well as cornified 
epidermal layers that are both mitotically and metabolically active. 
Tissues were equilibrated in 2.5 mL of EFT-400-MM media for 1 hour 
at 37°C/5%CO2. Media was replaced, and tissues were incubated at 
37°C/5%CO2 for 18 + 3 hours. On Day 1, tissues were equilibrated to 
room temperature for 90 minutes, after which basal electrical imped-
ance of the tissues was measured using a Nova Meter (NOVA™ DPM 
9003BT; NOVA Technology Corp.). Tissues were divided into three dif-
ferent groups of tissues (N = 5, each): untreated (negative control; NC), 
TRMT, and a market-leading moisturizer (MLM).
2.2.1 | Hydration evaluation
Tissues were topically treated for 60 minutes with 25 µL of the two 
test formulations; the third group of tissues remained untreated. 
Residual test formulations were removed from tissue surfaces with 
a sterile swab. Immediately 0, 15, and 30 minutes following removal, 
epidermal hydration was evaluated using a Nova Meter. Media was 
replaced and tissues were re-dosed with test formulations and incu-
bated at 37°C/5%CO2 for 24 ± 2 hours.
2.2.2 | Biomarker evaluation
On Day 2, tissues were harvested for gene expression analysis 
(N = 3, each). Tissues were then fixed in 8 mL of 10% formalin for 
24 ± 3 hours for histological processing and H&E staining. Key bio-
markers were analyzed using real-time quantitative polymerase 
chain reaction (RT qPCR), a standard laboratory technique in which 
 Key ingredient Skin benefits
Natural moisturizing 
factors (NMF)
Urea complex Increases skin's resiliency and 
provides intense moisturization





Carnosine Biomimetic peptide, targets glycation, 
supports promotion of NMF
Sodium lactate Helps retain water in the skin
Barrier function Cholesterol Lipid, enhances barrier function
Ceramides 1 and 3 Supports hydration, reinforces skin's 
barrier
Linoleic and linolenic 
acids
EFAs, support skin's barrier (Omega-6, 
Omega-3)
Carnitine Naturally occurring amino acid, 
restores and hydrates skin
Squalene Naturally occurs in skin, supports 
moisture retention
Hyaluronic acid Aminopropyl ascorbyl 
phosphate
Reduces HA degradation, increases 
skin smoothness
Sodium lactate Promotes HA, keeps skin soft, supple
Sodium hyaluronate Helps provide skin with high moisture 
retention, free-radical protection
Support Glycerin Provides hydration to skin
Caffeine Enhances hydration
Jojoba esters Provides hydration, supports skin's 
barrier
TA B L E  1   TRMT key ingredients
--------- r-- - - _- _- _- _- _--=-=-=---=---=---=---=- - WILEY 
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copies of genes are generated over a short period of time to allow 
for more accurate or robust measurement. cDNA was synthesized 
using total RNA with Qiagen reagents; total RNA was isolated using 
RNAqueous kit (Ambion; Thermo Fisher Scientific) following the 
manufacturer's procedure. Expression of the following biomarkers 
was evaluated: Aquaporin (AQP; proteins that transport water, glyc-
erol, and urea across cell membranes), Claudin (CLD; a component 
of tight junction proteins that regulates permeability of the stratum 
corneum), Hyaluronic Acid Synthase (HAS; an enzyme responsible 




After 60 minutes of treatment, tissues treated with TRMT exhibited 
higher hydration potential than a MLM immediately following re-
moval of product (456 vs 302 DPM Units, respectively). Additionally, 
TRMT-treated tissues retained hydration for a longer duration of 
time (at 15 and 30 minutes) where hydration effects were greater 
than that of an MLM.
Tissues treated with TRMT demonstrated statistically significant 
increases in hydration vs NC at 0, 15, and 30 minutes following ap-
plication (P < .005) (Figure 1). Tissues treated with TRMT demon-
strated up to 2x greater hydration effects compared with tissues 
treated with MLM.
2.3.2 | Expression of biomarkers
mRNA expression of epidermal barrier biomarkers was analyzed 
24 hours after treatment with TRMT and a MLM. TRMT-treated tis-
sues demonstrated greater expression of key biomarkers vs NC and 
MLM, with greater expression of CLD, AQP, and HAS. TRMT also 
substantially reduced expression of HYAL compared with the MLM 
(Figure 2A-D).
3  | EFFIC ACY AND TOLER ABILIT Y IN 
PHOTODAMAGED SKIN
3.1 | Study objectives
This open-label, dual-center study evaluated efficacy and toler-
ability in subjects with moderate to severe photodamaged skin fol-
lowing twice-daily application of TRMT over 8 weeks across two 
dermatology research centers.
3.2 | Study design and methods
This study evaluated improvements from baseline in the appear-
ance of fine lines/wrinkles, erythema, skin brightness, skin texture, 
and pore size at 2, 4, and 8 weeks based on a 6-point grading scale 
(0 = none, 1 = minimal, 2 = mild, 3 = moderate, 4 = moderately se-
vere, and 5 = severe) using expert-graded digital photographic as-
sessment (Canfield VISIA® CR). Subjects were instructed to apply 
TRMT to clean skin twice daily, AM and PM, for 8 weeks. In addition, 
changes in global improvement were evaluated at weeks 2, 4, and 8 
using a 5-point scale (0 = no improvement, 1 = minimal Improvement, 
2 = mild Improvement, 3 = Mmderate Improvement, and 4 = marked 
Improvement).
Changes in skin hydration were evaluated from baseline at 
weeks 2, 4, and 8 using noninvasive, bioinstrumentation (NOVA™ 
DPM 9003BT; NOVA Technology Corp.). Prior to imaging and skin 
hydration measurements, subjects were required to cleanse their 
face and acclimate to the treatment room for at least 30 minutes. 
Measurements were obtained by placing the probe with low pres-
sure in a vertical manner against the surface of the cheek; three con-
secutive readings were obtained from the same location. Increases 
in post-treatment readings from baseline indicate a hydrating effect 
resulting from increased skin moisture content, whereas decreases 
indicate a drying effect.
Subjects completed self-assessment questionnaires at weeks 2, 
4, and 8. Adverse events (AEs) were captured throughout the study 
period.
3.2.1 | Study subjects
Eligible subjects included healthy men and women between the 
ages of 35 and 65 years with moderate to severe photodamage, 
Fitzpatrick Skin Types (FST) II-V, and no known medical conditions 
that could interfere with study participation. Subjects agreed to 
use only sponsor-supplied skin-care products and minimize sun 
exposure. Subjects were excluded from study participation if 
they had any disorder which may have interfered with accurate 
evaluation (such as, but not limited to, any active inflammatory 
skin condition, severe acne vulgaris, acne conglobata, acne ful-
minans, facial seborrheic dermatitis, diabetes, chronic kidney or 
liver disease, autoimmune disease, or anyone undergoing cancer 
















0 Min . 15M III. 30 Mit1. 
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treatment, taking systemic steroid medication, or an immunosup-
pressive agent); were pregnant or breastfeeding; had concurrent 
use of topical or oral medication that could interfere with evalua-
tion; and/or concurrent or recent use of any skin-care product(s) 
(cosmetic, prescription, and nonprescription) or procedure(s) 
within the past 2 months, which may interfere with evaluation. 
Subjects were also excluded if they were unable or unwilling to 
comply with the study protocol, including refraining from sunbath-
ing. In order to minimize the potential influence of additional in-
gredients found in some moisturizers, such as peptides, growth 
factors, retinol, or AHAs, on baseline measurements, subjects 
routinely using any hydration cream(s) or moisturizer(s) at baseline 
underwent a brief 1-week washout period. There was no washout 
period regarding use of sunscreen. Throughout the study, subjects 
were instructed to apply a broad-spectrum sunscreen (SPF46) 
in the morning 30 minutes prior to being outdoors, reapply as 
needed, and to utilize a basic daily cleanser prior to application of 
the study product.
This study was conducted in accordance with all applicable 
guidelines for the protection of human subjects for research as out-
lined in 21 CFR 50, the accepted standards for Good Clinical Practice 
(GCP), and approved by Advarra IRB (Columbia, MD).
3.2.2 | Statistical methods
Mean (LS) improvement and mean (LS) percent improvement from 
baseline to each timepoint for category was analyzed using a t test. 
The significance of improvement over time was analyzed using a 
mixed effects model.
3.3 | Results
Forty subjects with an average age of 57 years were enrolled in this study; 
39 completed the study (one subject withdrew). The majority of subjects 
were female (1 male subject), FST III, and had moderate photodamage.
Expert assessments demonstrated significant mean percent im-
provements from baseline in the appearance of fine lines/wrinkles 
(15%; P < .0001), erythema (32%; P = .0009), skin brightness (144%; 
P < .0001), and skin texture (23%; P < .0001) following twice-daily use 
after 8 weeks (Figure 3A-C). Visible improvements in fine lines/wrin-
kles and skin texture were demonstrated as early as week 2, as well as 
a 54% increase in skin brightness from baseline (P < .0001). Statistically 
significant differences were observed in all categories by week 4, with 
continued, progressive improvements from baseline achieved in all cat-
egories by week 8. Nova Meter measurements demonstrated an 11% 
increase in hydration at 2 weeks (P < .004), 36% increase at 4 weeks 
(P < .0001), and 25% increase at 8 weeks (P = .0002) (Figure 4). Global 
improvement was statistically significant at all timepoints (P < .0001).
After 8 weeks, nearly all subjects reported that TRMT made their 
skin feel moisturized (97%), smoother (92%), softer (95%), less dry, and 
less rough (90%, each), and did not make their skin feel greasy (97%). 
Subjects reported that TRMT worked well with their makeup, and 
nearly all reported it absorbed easily. Prior to using TRMT, only 7% 
of subjects described their skin tone as bright, this increased to 48% 
at 4 weeks and 51% after 8 weeks of use. Similarly, the percentage of 
subjects who described their skin texture as smooth and soft doubled 
from 20% at study outset to 40% at 4 weeks and 54% at 8 weeks.
Adverse events deemed possibly related to study product in-
cluded perioral break-out (n = 2) and one subject who reported ex-
periencing rash/hives at 4 weeks leading to study discontinuation.
F I G U R E  2   Expression of epidermal 
barrier biomarkers in tissues: A, claudin 
(CLD); B, aquaporin (AQP), C, hyaluronic 
acid synthase (HAS), and D, hyaluronidase 
(HYAL)
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4  | DISCUSSION
Healthy, hydrated skin constantly renews itself and is able to main-
tain its protective barrier despite environmental insults and age-re-
lated changes.6,9 Sufficient hydration is essential for maintaining the 
skin's barrier11 and is dependent upon optimal levels of hyaluronic 
acid, NMF, and lipids to keep the barrier moisturized and hydrated. 
Clinical consequences of insufficient hydration include dry skin, 
manifestations of aging, and increased vulnerability to environmen-
tal factors.9
Moisturizers are a key component of every skin-care regi-
men.18 Ideal moisturizers mimic the skin's own natural moistur-
izing systems, and address primary goals including repairing and 
restoring the barrier and barrier function, and increasing hydration 
or water content on the skin.19 There are many types of moisturiz-
ers, and not all are designed to or capable of mitigating xerosis.14 
F I G U R E  3   A, Demonstrated 
improvements from baseline through 
week 8. B, Unretouched digital 
photography on clean face at Baseline 
and at week 8. C, Unretouched digital 
photography on clean face at Baseline 
and at week 8. * indicates statistical 
significance of P < .04 to P < .0001
WILEY - * (A) 150% 144% ■ Erythe ma 
Q) 
140% ■ Fine Lines/Wr inkles C: 
oi 
■ Skin Brightness "' 130% "' al 






90% * 0. 0. 
< 
80% _,:: 
t: 70% Q) 
E 
* Q) 60% i'i 
0.. 50% 





C: 20% "' Q) 
:;;; 10% 
0% 
8ASELINt Wt t K2 WetK4 Wt t K8 
p<0.04 - p<0.0001 
(B) 
(C) 
     |  1127McDANIEL Et AL.
While occlusive agents coat the skin with friction-reducing sub-
stances like silicones to increase skin smoothness, their benefits 
are temporary.14,15,18,19 More than just coating the surface of skin, 
effective moisturizers are capable of improving skin barrier ho-
meostasis and function. Additionally, ideal moisturizers are appro-
priate for use in sensitive and compromised skin, quickly absorbed, 
and long-lasting.13,14,20,21
The moisture treatment cream highlighted in these studies was 
designed to address three critical components essential to natural 
skin moisturization. This unique approach bolsters skin's innate mech-
anism for restoring and maintaining proper moisturization by support-
ing the modulation of hyaluronic acid, natural moisturizing factors and 
external barrier lipids for optimal functioning of the skin barrier.
Results from in vitro and in vivo studies performed support 
TRMT's effect on skin hydration and barrier function, as well as its 
effectiveness in enhancing hydration and visibly improving pho-
todamaged skin in healthy subjects. Using a reconstructed human 
epidermal skin model, tissues treated with TRMT demonstrated sta-
tistically significant increases in hydration at all timepoints vs un-
treated control and demonstrated up to two times greater hydration 
compared with a market-leading moisturizer. Tissues treated with 
TRMT demonstrated greater expression of CLD, AQP, and HAS vs a 
MLM. CLDs are proteins that are the most important components of 
tight junctions and thus play an important role in enhancing barrier 
function by regulating the flow of water through the epidermis.22 
AQPs function as molecular water channel proteins that transport 
and distribute water, glycerol, and urea throughout the epider-
mis.13,14 Hyaluronic acid is comparable to a skin hydration reser-
voir—attracting and maintaining moisture. Increased expression of 
HAS and decreased expression of HYAL, as was observed in tissues 
treated with TRMT, facilitates hyaluronan synthesis and increased 
water retention in the skin.
The physiologic benefits of TRMT demonstrated through gene 
expression analysis in the epidermal skin model translated to clini-
cally significant improvements in the appearance of photodamaged 
skin after 8 weeks of twice-daily application. TRMT use led to sig-
nificant improvements in the appearance of fine lines/wrinkles, 
erythema, skin brightness, and skin texture, as well as significant 
improvements in skin hydration based on objective biometric mea-
surements over 8 weeks. Despite extreme changes in temperatures 
during the winter months on the east coast, subjects continued to 
experience significant increases in hydration through week 8. TRMT 
was well tolerated and nearly all subjects reported that TRMT made 
their skin feel moisturized, smoother, and softer, and was cosmeti-
cally elegant—nongreasy and worked well with makeup.
Limitations of this study include conducting additional research 
in a larger population for a longer duration, as this would be benefi-
cial in understanding the long-term benefits of TRMT. Additionally, 
although it is routine to include washout periods when evaluating 
a new treatment in an effort to minimize the number of variables 
potentially attributed to treatment effects, subjects who regularly 
used moisturizers may have presented with drier skin at the baseline 
timepoint due to the 1-week washout period. Finally, in this study 
each subject served as their own control in measuring changes from 
baseline over an 8-week period. Additional studies may include the 
use of a separate control group.
5  | CONCLUSIONS
Together, these studies demonstrate the physiologic and clinical 
benefits of a new rebalancing moisture treatment cream. In an epi-
dermal skin model, TRMT increased hydration and expression of key 
markers associated with enhanced barrier function. These effects 
were greater than a market-leading moisturizer. Clinical manifesta-
tions of these effects led to significant increases in hydration and 
visible improvements in subjects with photodamaged skin as early 
as two weeks after treatment initiation, with continued progressive 
improvements through 8 weeks.
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